Endpoints Capital was founded to address the funding challenges that biotechnology companies face by providing a financing solution that benefits biotechs at all stages. We understand the life sciences ecosystem and the challenges - including financing - that biotech companies face getting their treatment or device into the clinic. This has been further compounded by the difficulties in capital markets in recent times. We are excited by the opportunity to help biotechs accelerate their discovery of new medicines, therapies and life changing treatments.
| Website | https://endpointscapital.com.au |
| Employees | 7 (2 on RocketReach) |
| Founded | 2023 |
| Address | 81-83 Campbell St, Surry Hills, New South Wales 2010, AU |
| Phone | +61 2 8188 1783 |
| Industry | Biotechnology Research |
| Keywords | Biotechnology Funding, Life Sciences Investment, Biotechnology Investment, Life Sciences Venture Capital, Venture Capital Biotech, Biotech Venture Capital, Pharmaceutical Funding, Biotech Investment Banking, Seed Funding Biotech, Early Stage Biotech, Healthcare Venture Capital, Private Equity Biotech, Pharmaceutical Investment, Biotech Incubator |
| Competitors | Blackbird, AirTree, Square Peg Capital, MSQ Ventures, Catapult Ventures, Tank Stream Ventures, Scale Investors Pty Ltd, Artesian (Alternative Investments), BlueChilli Group +42 more (view full list) |
Looking for a particular Endpoints Capital employee's phone or email?
Endpoints Capital Questions
Andrew Lewan is the Director, Risk and Portfolio Strategy of Endpoints Capital.
2 people are employed at Endpoints Capital.
Endpoints Capital is based in Surry Hills, New South Wales.
Top Endpoints Capital Employees
